TABLE 1

Demographic and clinical characteristics of study participants

VariableHIV-uninfected participantsaHIV-infected participants with toxicitya
Gender (n)
    Female55
    Male1111
Age (range) (yrs)33–6633–66
Race (%)
    White non-Hispanic2525
    White Hispanic66
    African American6969
Mean CD4 count (range) (count/μl)NAb523 (86–1336)
Mean viral load (range) (copies/ml)NA2,087 (20–29297)
Mean duration of exposure to nucleoside analogs (range) (yrs)NA8.18 (1–17)
Toxicities (%)
    SingleNA63
    MultipleNA38
Basis of treatment regimen (%)
    NNRTINA25
    PINA44
    IntegraseNA6
    PI/NNRTINA13
    PI/integraseNA6
    Integrase/NNRTINA6
  • a Sample size (n) = 16.

  • b NA, not applicable.